On December 24, 2025, Monash IVF Group Limited (ASX: MVF) announced that the consortium, consisting of Genesis Capital Investment Management and WHSP Holdings Pty Limited, has withdrawn its non-binding proposal to acquire 100% of Monash IVF shares at AU$0.80 per share via a Scheme of Arrangement. This decision follows the announcement on November 24, 2025. Monash IVF confirmed that if any further developments occur, they will disclose the information as per their continuous disclosure obligations.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Monash IVF Group: Acquisition Proposal Withdrawal
On December 24, 2025, Monash IVF Group Limited (ASX: MVF) announced that the consortium, consisting of Genesis Capital Investment Management and WHSP Holdings Pty Limited, has withdrawn its non-binding proposal to acquire 100% of Monash IVF shares at AU$0.80 per share via a Scheme of Arrangement. This decision follows the announcement on November 24, 2025. Monash IVF confirmed that if any further developments occur, they will disclose the information as per their continuous disclosure obligations.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au